The purpose of this study is to evaluate possible mechanisms of aspirin resistance at a
molecular level in aspirin-treated patients with coronary artery disease. We hypothesize that
certain patient characteristics associate with aspirin resistance. In addition, we will
compare the effects of enteric-coated aspirin and chewable aspirin.
Phase:
Early Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center